Verve Therapeutics Statistics
Total Valuation
UMB Financial has a market cap or net worth of $8.37 billion. The enterprise value is $9.83 billion.
Important Dates
The last earnings date was Tuesday, July 29, 2025, after market close.
Earnings Date | Jul 29, 2025 |
Ex-Dividend Date | Sep 10, 2025 |
Share Statistics
UMB Financial has 75.93 million shares outstanding. The number of shares has increased by 22.80% in one year.
Current Share Class | 75.93M |
Shares Outstanding | 75.93M |
Shares Change (YoY) | +22.80% |
Shares Change (QoQ) | +16.41% |
Owned by Insiders (%) | 3.08% |
Owned by Institutions (%) | 84.41% |
Float | 72.83M |
Valuation Ratios
The trailing PE ratio is 12.61 and the forward PE ratio is 10.36. UMB Financial's PEG ratio is 1.22.
PE Ratio | 12.61 |
Forward PE | 10.36 |
PS Ratio | 3.37 |
Forward PS | 3.06 |
PB Ratio | 1.22 |
P/TBV Ratio | 1.84 |
P/FCF Ratio | 12.62 |
P/OCF Ratio | 11.86 |
PEG Ratio | 1.22 |
Financial Ratio History Enterprise Valuation
EV / Earnings | 18.75 |
EV / Sales | 5.04 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | 14.82 |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | 5.63 |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 10.05%.
Return on Equity (ROE) | 10.05% |
Return on Assets (ROA) | 0.91% |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | n/a |
Revenue Per Employee | $527,136 |
Profits Per Employee | $141,791 |
Employee Count | 3,698 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
In the past 12 months, UMB Financial has paid $120.21 million in taxes.
Income Tax | 120.21M |
Effective Tax Rate | 18.53% |
Stock Price Statistics
The stock price has increased by +20.15% in the last 52 weeks. The beta is 0.78, so UMB Financial's price volatility has been lower than the market average.
Beta (5Y) | 0.78 |
52-Week Price Change | +20.15% |
50-Day Moving Average | 106.64 |
200-Day Moving Average | 108.88 |
Relative Strength Index (RSI) | 54.71 |
Average Volume (20 Days) | 618,335 |
Short Selling Information
The latest short interest is 2.20 million, so 2.90% of the outstanding shares have been sold short.
Short Interest | 2.20M |
Short Previous Month | 2.53M |
Short % of Shares Out | 2.90% |
Short % of Float | 3.03% |
Short Ratio (days to cover) | 3.14 |
Income Statement
In the last 12 months, UMB Financial had revenue of $1.95 billion and earned $524.34 million in profits. Earnings per share was $8.74.
Revenue | 1.95B |
Gross Profit | 1.95B |
Operating Income | 722.60M |
Pretax Income | 460.77M |
Net Income | 524.34M |
EBITDA | n/a |
EBIT | n/a |
Earnings Per Share (EPS) | $8.74 |
Full Income Statement Balance Sheet
The company has $2.27 billion in cash and $3.73 billion in debt, giving a net cash position of -$1.46 billion or -$19.27 per share.
Cash & Cash Equivalents | 2.27B |
Total Debt | 3.73B |
Net Cash | -1.46B |
Net Cash Per Share | -$19.27 |
Equity (Book Value) | 7.29B |
Book Value Per Share | 90.63 |
Working Capital | -50.81B |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was $705.18 million and capital expenditures -$42.10 million, giving a free cash flow of $663.08 million.
Operating Cash Flow | 705.18M |
Capital Expenditures | -42.10M |
Free Cash Flow | 663.08M |
FCF Per Share | $8.73 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | 37.07% |
Pretax Margin | 33.27% |
Profit Margin | 27.10% |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | 34.02% |
Dividends & Yields
This stock pays an annual dividend of $1.60, which amounts to a dividend yield of 1.47%.
Dividend Per Share | $1.60 |
Dividend Yield | 1.47% |
Dividend Growth (YoY) | 2.56% |
Years of Dividend Growth | 32 |
Payout Ratio | 18.31% |
Buyback Yield | -22.80% |
Shareholder Yield | -21.33% |
Earnings Yield | 6.27% |
FCF Yield | 7.93% |
Dividend Details Analyst Forecast
The average price target for UMB Financial is $133.22, which is 20.88% higher than the current price. The consensus rating is "Buy".
Price Target | $133.22 |
Price Target Difference | 20.88% |
Analyst Consensus | Buy |
Analyst Count | 9 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | |
Lynch Upside | |
Graham Number | |
Graham Upside | |
Stock Splits
The last stock split was on May 31, 2006. It was a forward split with a ratio of 2:1.
Last Split Date | May 31, 2006 |
Split Type | Forward |
Split Ratio | 2:1 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 4 |